Fujian Provincial
Fuzhou, Fujian, 350001, China
NCT Number: NCT03763968
This is a multicentre observational study planned to gather follow up data for a period of 1 year in order to understand the treatments and outcomes of ST-segment elevation myocardial infarction(STEMI) and improve medical care quality in Fujian province for China. Consecutive patients who were admitted and diagnosed with STEMI between January 2014 December 2018 were conducted at five regional representative hospitals in Fujian province, which included the Fujian Provincial Hospital,Longyan First Hospital, the affiliated hospital of putian university,the Second Affiliated Hospital of Fujian Medical University and Mindong Hospital of Ningde City.
Looking for future studies?
Notify MeAll sexes
Observational
Fuzhou, Fujian, 350001, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: 5years
all mortality,cardiovascular mortality
Time frame: 5years
recurrent myocardial infarction, target vessel revascularization,contrast-induced acute kidney injury,stroke,bleeding,and so on
Time frame: 1 year
mortality,stent restenosis, recurrent myocardial infarction, and target vessel revascularization,stroke,bleeding,and so on
Yan-song Guo
Other
Multicentre REtrospective StuDy of Treatment and OUtComes in ST-elevatION Myocardial Infarction(STEMI) Patients in Fujian Province
Acronym: REDUCTION
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02445885
Cardiovascular Diseases, Heart Diseases
Copenhagen, Capital Region, Denmark
View Trial DetailsNCT05895123
Cardiovascular Diseases, Heart Diseases
Damanhūr, Egypt
View Trial DetailsNCT02641262
Cardiovascular Diseases, Heart Diseases
Zhengzhou, Henan, China
View Trial DetailsNCT03671603
Arterial Occlusive Diseases, Arteriosclerosis
Kaifeng, Contact:, China
View Trial Details